We are live on
!
Find out more
TCM
TimesSquare Capital Management Portfolio holdings
AUM
$6.8B
1-Year Est. Return
45.85%
This Fund
S&P 500
This Quarter
Est. Return
-17.15%
1 Year Est. Return
+45.85%
3 Year Est. Return
+131.54%
5 Year Est. Return
+149.79%
10 Year Est. Return
+765.84%
AUM
$8.39B
AUM Growth
-$2.83B
(-25%)
Cap. Flow
-$558M
Cap. Flow
% of AUM
-6.65%
Top 10 Holdings %
Top 10 Hldgs %
14.4%
Holding
248
New
31
Increased
82
Reduced
108
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RenaissanceRe
RNR
|
+$141M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$61.4M |
| 3 |
Cencora
COR
|
+$54.7M |
| 4 |
Twilio
TWLO
|
+$48.8M |
| 5 |
Synopsys
SNPS
|
+$47.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global Payments
GPN
|
+$80.7M |
| 2 |
Hexcel
HXL
|
+$75.2M |
| 3 |
Corpay
CPAY
|
+$67.7M |
| 4 |
NUVA
NuVasive, Inc.
NUVA
|
+$66.2M |
| 5 |
Dolby
DLB
|
+$63.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.72% |
| 2 | Healthcare | 17.67% |
| 3 | Industrials | 16.97% |
| 4 | Financials | 9.79% |
| 5 | Consumer Discretionary | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Bright Horizons
BFAM
$3.83B
| $19.8M | 0.24% |
193,800
-203,276
| -51% | -$29.9M |
|
152
AptarGroup
ATR
$8.54B
| $19.7M | 0.24% |
198,300
+68,100
| +52% | +$7.38M |
|
153
Clarivate
CLVT
$1.29B
| $19.7M | 0.23% |
+947,300
| New | +$19M |
|
154
Phreesia
PHR
$773M
| $19.6M | 0.23% |
930,900
-157,000
| -14% | -$4.3M |
|
155
WillScot Mobile Mini Holdings
WSC
$4.21B
| $19.3M | 0.23% |
1,910,000
-57,700
| -3% | -$937K |
|
|
NSTG
156
DELISTED
NanoString Technologies, Inc.
NSTG
| $19M | 0.23% |
791,835
-24,785
| -3% | -$717K |
|
157
Performance Food Group
PFGC
$17.9B
| $18.9M | 0.23% |
765,300
-56,400
| -7% | -$2.43M |
|
158
BILL Holdings
BILL
$4.94B
| $18.7M | 0.22% |
547,900
+507,900
| +1,270% | +$24M |
|
|
RST
159
DELISTED
ROSETTA STONE INC
RST
| $18.6M | 0.22% |
1,326,660
-291,305
| -18% | -$4.89M |
|
160
Malibu Boats
MBUU
$580M
| $18.1M | 0.22% |
630,045
+76,545
| +14% | +$3.04M |
|
161
ScottsMiracle-Gro
SMG
$3.6B
| $17.7M | 0.21% |
173,000
-68,300
| -28% | -$7.51M |
|
162
Azenta
AZTA
$1.52B
| $17.7M | 0.21% |
579,140
-5,710
| -1% | -$208K |
|
163
Nice
NICE
$6.04B
| $17.6M | 0.21% |
122,850
+3,500
| +3% | +$565K |
|
164
argenx
ARGX
$53.7B
| $16.2M | 0.19% |
122,895
+11,560
| +10% | +$1.69M |
|
165
CRISPR Therapeutics
CRSP
$5.16B
| $15.4M | 0.18% |
+363,350
| New | +$18.8M |
|
166
Assured Guaranty
AGO
$3.36B
| $14.8M | 0.18% |
574,200
-560,475
| -49% | -$23.2M |
|
167
Gentex
GNTX
$5.06B
| $14.2M | 0.17% |
+639,800
| New | +$17.8M |
|
168
BridgeBio Pharma
BBIO
$16.5B
| $14.1M | 0.17% |
487,650
-7,900
| -2% | -$245K |
|
169
Trex
TREX
$5.03B
| $13.8M | 0.16% |
+344,600
| New | +$16.1M |
|
170
Pegasystems
PEGA
$5.45B
| $13.5M | 0.16% |
380,410
-262,790
| -41% | -$11M |
|
|
HUD
171
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $13.5M | 0.16% |
2,683,750
-41,120
| -2% | -$407K |
|
172
1-800-Flowers.com
FLWS
$258M
| $13.4M | 0.16% |
+1,010,900
| New | +$15.6M |
|
173
Rush Enterprises Class A
RUSHA
$9.48B
| $13.3M | 0.16% |
+934,841
| New | +$16.9M |
|
174
Planet Fitness
PLNT
$3.61B
| $13.1M | 0.16% |
+268,980
| New | +$18.8M |
|
|
SBNY
175
DELISTED
Signature Bank
SBNY
| $12.9M | 0.15% |
160,000
+60,000
| +60% | +$7.53M |
|
Similar funds
CF
JCAM
GAM
CIMLRA
SPC
SPS
BHM
MSE
TimesSquare Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, TimesSquare Capital Management held 248 positions worth $8.39B, down 25% from $11.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
TimesSquare Capital Management withdrew a net $558M in Q1 2020, closing 26 positions and reducing 108 holdings. Its most notable exit was Hexcel, an estimated $75.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, TimesSquare Capital Management opened a new position in Alexion Pharmaceuticals worth $56.2M.
- TimesSquare Capital Management's largest Q1 2020 buy was Alexion Pharmaceuticals: 625,500 shares worth $56.2M.
- TimesSquare Capital Management added most to RenaissanceRe in Q1 2020, an estimated $141M increase.
- TimesSquare Capital Management's biggest Q1 2020 reduction was Global Payments, cutting an estimated $80.7M.
- TimesSquare Capital Management fully exited Hexcel in Q1 2020, selling an estimated $75.2M.
- TimesSquare Capital Management's ten largest holdings make up 14% of its $8.39B portfolio in Q1 2020.
- TimesSquare Capital Management opened 31 new positions and closed 26 in Q1 2020.
- TimesSquare Capital Management's portfolio value fell 25% quarter-over-quarter to $8.39B.
Based on TimesSquare Capital Management's 13F filing for Q1 2020, filed 8 May 2020.